New Developments in Intracranial Stereotactic Radiotherapy for Metastases.
AffiliationDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractBrain metastases are common and the prognosis for patients with multiple brain metastases treated with whole brain radiotherapy is limited. As systemic disease control continues to improve, the expectations of radiotherapy for brain metastases are growing. Stereotactic radiosurgery (SRS) as a high precision localised irradiation given in a single fraction prolongs survival in patients with a single brain metastasis and functional independence in those with up to three brain metastases. SRS technology has become commonplace and is available in many radiation oncology and neurosurgery departments. With increasing use there is a need for appropriate patient selection, refinement of dose-fractionation and safe integration of SRS with other treatment modalities. We review the evidence for current practice and new developments in the field, with a specific focus on patient-relevant outcomes.
CitationNew Developments in Intracranial Stereotactic Radiotherapy for Metastases. 2015: Clin Oncol
- Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
- Authors: Xue J, Kubicek GJ, Grimm J, LaCouture T, Chen Y, Goldman HW, Yorke E
- Issue date: 2014 Dec
- Stereotactic radiosurgery for multiple brain metastases.
- Authors: Lam TC, Sahgal A, Chang EL, Lo SS
- Issue date: 2014 Oct
- [Stereotactic radiosurgery and radiotherapy for brain metastases].
- Authors: Tanguy R, Métellus P, Mornex F, Mazeron JJ
- Issue date: 2013 Jan 1
- Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
- Authors: Chidel MA, Suh JH, Reddy CA, Chao ST, Lundbeck MF, Barnett GH
- Issue date: 2000 Jul 1
- The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
- Authors: Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD
- Issue date: 2005 Jul 15